share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  06/04 16:25
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
SeaStar Medical Holding Corporation, a company listed on The Nasdaq Stock Market under the trading symbol ICU, held a virtual Special Meeting of stockholders on June 4, 2024. During the meeting, stockholders voted on several key proposals. Three Class II Directors were elected to serve until the 2027 annual meeting: Allan Collins, MD, Jennifer A. Baird, and Bernadette N. Vincent. An amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan was approved, increasing the authorized shares of common stock from 3,278,457 to 9,778,457. Additionally, the issuance of more than 20% of the Company's outstanding shares of Common Stock upon exercise of Series A and Series B Warrants was approved, in compliance with Nasdaq Listing Rule 5635(d). The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was also ratified.
SeaStar Medical Holding Corporation是一家在納斯達克股票市場上以交易符號ICU上市的公司，於2024年6月4日舉行了一場虛擬的股東特別會議。在此次會議中，股東們對幾個關鍵提議進行了投票。三位II級董事被選為其任期直至2027年年度股東大會的董事：Allan Collins、MD、Jennifer A. Baird和Bernadette N. Vincent。通過了公司2022年全面權益激勵計劃的修訂和重簽，將普通股的授權股份從3,278,457股增加到9,778,457股。此外，公司通過了股票上市規則5635(d)的要求，批准以行使A和B系列認股權形式發行超過公司流通普通股的20%以上。獨立註冊公共會計師事務所WithumSmith+Brown, PC被任命為公司獨立註冊公共會計師，其任期為截至2024年12月31日的財政年度。
SeaStar Medical Holding Corporation是一家在納斯達克股票市場上以交易符號ICU上市的公司，於2024年6月4日舉行了一場虛擬的股東特別會議。在此次會議中，股東們對幾個關鍵提議進行了投票。三位II級董事被選為其任期直至2027年年度股東大會的董事：Allan Collins、MD、Jennifer A. Baird和Bernadette N. Vincent。通過了公司2022年全面權益激勵計劃的修訂和重簽，將普通股的授權股份從3,278,457股增加到9,778,457股。此外，公司通過了股票上市規則5635(d)的要求，批准以行使A和B系列認股權形式發行超過公司流通普通股的20%以上。獨立註冊公共會計師事務所WithumSmith+Brown, PC被任命為公司獨立註冊公共會計師，其任期為截至2024年12月31日的財政年度。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息